Pharmaceutical Isolator Market

Global Pharmaceutical Isolator Market Size (2023 to 2028)

From 2023 to 2028, the global pharmaceutical isolator market is estimated to grow at a CAGR of 5.2% and be worth USD 14242.59 million by 2028 from USD 11053.76 million in 2023.

Pharmaceutical isolators are also called containment isolators or glove boxes. These are used in the pharmaceutical industry for the harmless manufacturing of products. Pharmaceutical isolators aid in providing highly controlled environments that can limit the contamination of the product and protect the workforce and the environment from exposure to hazardous materials. The usage of pharmaceutical isolators can be majorly seen in activities such as sterile compounding, material handling, and testing of pharmaceutical products. These are further primarily used for the manufacturing of potency drugs. The manufacturing of potency drugs is complex and can cause significant damage to the operator and the environment if exposed. Pharmaceutical isolators are available in various sizes and configurations that majorly depend on the application.

Impact of COVID-19 on the global pharmaceutical isolator market:

The COVID-19 pandemic has risen to the top of the global threat list. It has caused havoc in a variety of trades and enterprises all around the world. On the other hand, the pandemic has provided various chances for pharmaceutical and biopharmaceutical companies to expand their research and development efforts to create novel vaccines against the novel coronavirus. Companies are conducting clinical trials to stop the spread of the COVID-19 virus. As a result of the growing number of clinical studies, pharmaceutical isolator providers for pharmaceutical businesses will have more chances.

MARKET DRIVERS:

The rising demand for sterile drug manufacturing is majorly propelling the pharmaceutical isolator market growth.

Currently, the need for sterile drug manufacturing is growing significantly owing to the growing patient population suffering from chronic diseases and increasing demand for quality drugs. The growing usage of pharmaceutical isolators to provide a sterile environment for drug manufacturing is expected to result in market growth. The demand for sterile drugs has increased notably in recent years. The growing aging population, increasing patient count suffering from chronic diseases, and rising emphasis on patient safety propel the need for sterile drugs. The manufacturing, packaging, and handling of sterile drugs are complex and require a highly controlled environment to do so. Pharmaceutical isolators can help build such types of environments, and the adoption of pharmaceutical isolators has also grown with the growing demand for sterile drugs.

Stringent regulations for pharmaceutical manufacturing are further fuelling the pharmaceutical isolators market growth.

Several countries have imposed strict regulations for the manufacturing of pharmaceutical products to ensure the safety and effectiveness of the drugs. Pharmaceutical isolators can help develop highly controlled environments for manufacturers that can comply with the available regulations related to drug production and handling. For instance, regulatory bodies such as the USFDA and European Medicine Agency (EMA) recommend using isolators in manufacturing procedures to prevent contamination in sterile drug manufacturing and aseptic processing.

Increasing adoption of personalized medicine is expected to promote the pharmaceutical isolator market growth.

The awareness and adoption of personalized medicine have grown significantly in recent years owing to the advantages of personalized medicine, such as improved patient life and quality outcomes. The manufacturing of personalized medicine requires the high precision and sterility that pharmaceutical isolators can offer. Likewise, the growing demand for personalized medicine is contributing to the growth of the pharmaceutical isolators market.

In addition, many pharmaceutical companies are willing to outsource their manufacturing and testing activities to CMOs and CROs due to the benefits associated, such as cost savings and improved efficiency, and this trend is anticipated to accelerate in the coming years and boost the demand levels for pharmaceutical isolators among the contract organizations. Furthermore, the growing emphasis on occupational health and safety by companies to safeguard their workers is estimated to support market growth. Furthermore, factors such as increasing healthcare expenditure, rapid adoption of technological advancements in manufacturing pharmaceutical isolators, rising demand for biologics, increasing investments for R&D, and growing emphasis on quality assurance are anticipated to fuel the growth rate of the pharmaceutical isolators market.

MARKET RESTRAINTS:

The expense of pharmaceutical isolators is one of the key factors hampering the market growth. These costs are comparatively much higher than the traditional cleanrooms and becoming difficult for smaller companies to adopt. In addition, the availability of alternative technologies is expected to limit the adoption of pharmaceutical isolators and hamper the market’s growth rate. In addition, the scarcity of skilled professionals with expertise in executing the systems that work pharmaceutical isolators in some countries and the presence of a stringent regulatory landscape for pharmaceutical isolators are further hindering market growth.

REPORT COVERAGE:

This research report on the global pharmaceutical isolator market has been segmented and sub-segmented based on product type, configuration, application, end-user, and region.

Pharmaceutical Isolator Market– By Product Type:

• Closed Isolator Systems
• Open Isolator Systems

Based on product type, the open isolator systems segment had the largest share of the worldwide market in 2022 and is predicted to witness the fastest CAGR over the forecast period. The benefits of open isolator systems, such as flexibility and easier access to the workspace, are majorly propelling segmental growth.

However, the closed isolator systems segment is anticipated to hold a considerable share of the worldwide market during the forecast period. Installing closed isolator systems is simple and provides benefits such as substantial air flow, accurate air classification, and validation for door locks.

Pharmaceutical Isolator Market– By Configuration:

• Floor-standing
• Modular
• Mobile
• Compact
• Tabletop
• Portable

Based on the configuration, the floor-standing segment is expected to hold the most significant share of the global market and register the highest CAGR during the forecast period. The growing adoption of floor-standing isolators for high-volume manufacturing is one of the key factors fuelling segmental growth. Furthermore, the benefits associated with floor-standing isolators such as durability, stability, higher capacity, and ease of use, further contribute to the segment’s growth rate. In addition, floor-standing isolators are customizable and offer a high degree of safety to the product and operators, which further supports segmental growth. Furthermore, the growing demand for pharmaceutical manufacturing processes in developing countries propels the segment’s growth rate.

Pharmaceutical Isolator Market– By Application:

• Aseptic
• Containment
• Sampling and Weighing
• Fluid Dispensing

Based on application, the aseptic isolators segment is predicted to hold a major share of the worldwide market during the forecast period. Aseptic isolators play a crucial role in providing a sterile environment while filling and packaging sterile products. The segmental growth is majorly driven by the growing demand for sterile products and the increasing focus on patient safety. In addition, a stringent regulatory environment for aseptic manufacturing is further contributing to the segment's growth rate. On the other hand, the containment isolators segment is predicted to have a considerable share of the global pharmaceutical isolators market during the forecast period.

Pharmaceutical Isolator Market – By End-user:

• Pharmaceutical Companies
• Academic & Research Institutes
• Hospitals
• Contract Research Organizations

Based on end-user, the pharmaceutical companies segment is predicted to occupy a major share of the global pharmaceutical isolators market during the forecast period. Pharmaceutical companies are the largest consumers of pharmaceutical isolators used in manufacturing drugs and biologics. In addition, pharmaceutical companies are investing significant amounts in the research and developmental activities of new drugs and require a wide range of equipment and technologies, including pharmaceutical isolators.

The CROs segment accounted for the second-largest share of the global market in 2022 and is expected to hold a considerable share of the worldwide market during the forecast period.

Pharmaceutical Isolator Market – By Region:

• North America
• Asia Pacific
• Europe
• Latin America
• The Middle East and Africa

Geographically, the North American region was the largest regional segment for pharmaceutical isolators worldwide and is expected to hold dominating position in the global market during the forecast period. The presence of numerous pharmaceutical companies is majorly propelling the North American market. In addition, the stringent regulatory environment for pharmaceutical isolators for drug manufacturing and rising demand for sterile drugs and biologics are expected to boost the North American pharmaceutical isolators market growth. Furthermore, increasing investments by pharmaceutical companies for the R&D of new drugs and rapid adoption of technological advancements in manufacturing effective pharmaceutical isolators are anticipated to fuel the growth rate of the North American market. During the forecast period, the U.S. market is estimated to capture a major share of the North American market, followed by Canada.

The APAC regional market is estimated to register the fastest CAGR among all the regions in the worldwide market during the forecast period. The growing demand for pharmaceuticals in the APAC countries is one of the major factors propelling the regional market growth. Furthermore, the growing number of initiatives and investments by the APAC countries to develop the healthcare infrastructure and the growing adoption of technological advancements are promoting the growth rate of the APAC market. In addition, the growing number of initiatives by the APAC governments in favor of pharmaceutical isolators and the rising preference from pharmaceutical companies to outsource their drug development and manufacturing activities to countries such as India and China are further favoring regional market growth.

The European pharmaceutical isolator market is another potential regional market for pharmaceutical isolators. During the forecast period, the European region is expected to capture a substantial share of the global market.

The presence of an increasing number of pharmaceutical companies and research institutes and rising emphasis on patient safety are predicted to favor the European market growth.

The Latin American region is predicted to have decent occupancy in the worldwide market during the forecast period.

The MEA market is expected to showcase a moderate CAGR in the coming years.

KEY MARKET PARTICIPANTS:

SKAN, Getinge, Extract Technology (Walker), Comecer, Hosokawa Micron, ZHEJIANG TALIN Bioengineering, Fedegari Autoclave, Telstar, Syntegon, Bioquell, Shanghai Tofflon Science and Technology, Wenzhou Weike Biological Laboratory Equipment, IsoTech Design and Flow Sciences, Inc. (FSI) are some of the noteworthy companies operating in the global pharmaceutical isolator market.

RECENT MARKET DEVELOPMENTS:

• Fedegari and Berkshire Sterile Manufacturing teamed together in April 2020 to develop new COVID-19 treatment drugs. BSM just completed the first fill and is now anticipating accelerating the manufacturing of the experimental medicines to combat the coronavirus and contribute to life-saving efforts.
• In December 2022, to increase its testing and development capabilities, Berkshire Sterile Manufacturing (BSM), a fill-finish CDMO with headquarters in Massachusetts, acquired and verified three new analytical instruments. While sterile filtration and parenteral filling is the company's leading service, BSM also offers analytical support for on-site drug product lots and extensive development services.
• In December 2022, Pfizer sent another large amount of money east into continental Europe shortly after making a significant growth commitment in Ireland. One day after announcing plans for an equivalent investment in Dublin, the business announced on Friday that it would invest 1.2 billion euros in its manufacturing facility in Puurs, Belgium. 
• In October 2022, Tema Sinergie developed a brand-new pharmaceutical isolator for aseptically sampling sterile powders (API). The need for aseptic sampling of large quantities of sterile active components and for handling big containers led to the development of the Aseptic Sampling Isolator (AP-IS Series).